
Sign up to save your podcasts
Or
Paul A. Offit, MD, of The Children's Hospital of Philadelphia returns to JAMA's Q&A series to provide an update on the emergence of COVID-19 variants and their implications for vaccine development, including the Johnson & Johnson vaccine, scheduled for a US Food and Drug Administration VRBPAC hearing on February 26, 2021. Recorded February 11, 2021.
Related Article:
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants
4.6
162162 ratings
Paul A. Offit, MD, of The Children's Hospital of Philadelphia returns to JAMA's Q&A series to provide an update on the emergence of COVID-19 variants and their implications for vaccine development, including the Johnson & Johnson vaccine, scheduled for a US Food and Drug Administration VRBPAC hearing on February 26, 2021. Recorded February 11, 2021.
Related Article:
SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants
758 Listeners
38,523 Listeners
133 Listeners
314 Listeners
21,673 Listeners
861 Listeners
493 Listeners
43,353 Listeners
6,681 Listeners
692 Listeners
3,327 Listeners
17 Listeners
18 Listeners
14 Listeners
23 Listeners
6 Listeners
90 Listeners
29 Listeners
192 Listeners
349 Listeners
6,210 Listeners
18 Listeners